Featured Articles

Linkstorm And London's GMW Media Partner To Offer New, High-Performing Display Ad Solutions To U.K. Market

Linkstorm And London's GMW Media Partner To Offer New, High-Performing Display Ad Solutions To U.K. Market

Dec 19 2007 | comment(s)

NEW YORK and LONDON, December 19 /PRNewswire/ --

- Strategic Partnership Expands Linkstorm's Reach in European Market

Advertising technology company Linkstorm is ramping up its sales effort in the European online advertising business thanks to a new partnership with GMW Media, Ltd., a United Kingdom-based independent online media sales house.

GMW Media was founded in 2005 by Mark Wright, a veteran in online sales who has worked for companies such as Rivals.net, Sports.com, Teamtalk Media and Sportinglife. The company offers Linkstorm an extended sales team with local market know-how and contacts, thus raising Linkstorm's visibility with GMW's fast-growing network of advertisers and publishers.

Thomson Scientific Bestows Award Celebrating Innovation And Entrepreneurship In India

Thomson Scientific Bestows Award Celebrating Innovation And Entrepreneurship In India

Dec 19 2007 | comment(s)

PHILADELPHIA and LONDON, December 19 /PRNewswire/ --

- Award Winners were Chosen for Leading Innovation Through Technology in all Aspects of Scientific Literature and Patent Publications

Thomson Scientific, part of The Thomson Corporation (NYSE: TOC; TSX: TOC) and leading provider of information solutions to the worldwide research and business communities, today announced the winners of the 2007 Innovation Award, recognizing leadership in technology as it relates to all aspects of scientific literature and patent publications in India.

NUKEM Hands Over Engineered Near Surface Disposal Facility In Chernobyl To The Customer

NUKEM Hands Over Engineered Near Surface Disposal Facility In Chernobyl To The Customer

Dec 19 2007 | comment(s)

ALZENAU, Germany and CHERNOBYL, Ukraine, December 19 /PRNewswire/ -- NUKEM Technologies GmbH, Alzenau has handed over the Engineered Near Surface Disposal Facility at Chernobyl to the customer SSE Technocenter on 19 December 2007. By doing so, NUKEM as the first Western company, has successfully completed a plant for the treatment of radioactive waste on location Chernobyl up to the handover to the customer.

In the Engineered Near Surface Disposal Facility, short-life radioactive wastes accumulated in the nuclear power plant Chernobyl are stored following prior conditioning. The repository is situated 17 kilometres away from the power plant at the location VEKTOR within the 30-km zone.

An International First At The CHUM - Promising Treatment In Regeneration Of The Myocardium Through The Use Of Stem Cells

An International First At The CHUM - Promising Treatment In Regeneration Of The Myocardium Through The Use Of Stem Cells

Dec 19 2007 | comment(s)

Marvell And Samsung Announce Shipment Of New PDA Phone In Korea

Marvell And Samsung Announce Shipment Of New PDA Phone In Korea

Dec 19 2007 | comment(s)

SANTA CLARA, California, December 19 /PRNewswire/ --

- Marvell PXA 300 Application Processor Delivers Both Outstanding Multimedia and Optimal Business Applications Functionality

Marvell, (Nasdaq: MRVL), a leader in storage, communications, and consumer silicon solutions, and Samsung, announced the availability of the Samsung SPH-M4650 PDA phone with the Marvell(R) PXA 300 application processor running on Korea's LG Telecom network. The Marvell PXA 300 application processor enables high-end graphics, gaming, and multimedia capabilities for the Samsung SPH-M4650 as well as delivering optimal business applications while consuming ultra-low levels of power. The Samsung SPH-M4650 runs on the Microsoft Windows Mobile 6.0 Professional operating system.

Kiadis Pharma Reports Successful End Of Phase II Meeting With FDA For Reviroc

Kiadis Pharma Reports Successful End Of Phase II Meeting With FDA For Reviroc

Dec 19 2007 | comment(s)

AMSTERDAM, December 19 /PRNewswire/ --

- FDA Offers Special Protocol Assessment for Reviroc

Kiadis Pharma announced today that it has successfully completed an End of Phase II meeting for Reviroc with the U.S. Food and Drug Administration (FDA). Reviroc is under development for elimination of cancer cells from an autologous graft in bone marrow transplantations for end-stage blood cancer patients. The FDA agreed that the data from the completed phase II clinical Reviroc trial is sufficient to support the start of a phase III study. The FDA offered Kiadis Pharma its Special Protocol Assessment (SPA) procedure allowing Kiadis Pharma to work directly with the FDA to optimize the clinical design of the trial.

CSL Behring Expands Into Middle East Market With Haemate(R) P

CSL Behring Expands Into Middle East Market With Haemate(R) P

Dec 19 2007 | comment(s)

KING OF PRUSSIA, Pennsylvania, December 19 /PRNewswire/ --

- High levels of Type III von Willebrand Disease, a serious, hereditary bleeding disorder, found in region

A Genetic Foundation For Recognizing Faces

A Genetic Foundation For Recognizing Faces

Dec 19 2007 | comment(s)

A new study of twins indicates that the genetic foundation for the brain’s ability to recognize faces and places is much stronger than for other objects, such as words. The results, which appear in the December 19 issue of the Journal of Neuroscience, are some of the first evidence demonstrating the role of genetics in assigning these functions to specific regions of the brain.

“We are social animals who have specialized circuitry for faces and places,” says Arthur W. Toga, PhD, director of the Laboratory of NeuroImaging at UCLA School of Medicine. “Some people are better at recognizing faces and places, and this study provides evidence that it is partially determined by genetics.”

ROO Group Announces Strategic Realignment, Appointment Of New CEO, Reduction Of Workforce And Board Of Directors

ROO Group Announces Strategic Realignment, Appointment Of New CEO, Reduction Of Workforce And Board Of Directors

Dec 19 2007 | comment(s)

NEW YORK, December 19 /PRNewswire/ --

- Digital Media Vet Kaleil Isaza Tuzman to become Chairman and CEO and to Appoint new Slate of Directors

ROO Group (OTC Bulletin Board: RGRP) announced today that the company has entered into an Executive Management Agreement with KIT Capital pursuant to which it has agreed to appoint Kaleil Isaza Tuzman as Chairman and Chief Executive Officer commencing on January 9th, 2008. Mr. Isaza Tuzman will succeed Robert Petty, who will retain the office of Vice-Chairman of the Board of Directors and Founder.

Merck KGaA And Idera Pharmaceuticals To Collaborate On Development Of TLR9 Agonists For Treatment Of Cancer

Merck KGaA And Idera Pharmaceuticals To Collaborate On Development Of TLR9 Agonists For Treatment Of Cancer

Dec 19 2007 | comment(s)

GENEVA, Switzerland, December 19 /PRNewswire/ -- Merck KGaA announced today that it has entered into a worldwide licensing and collaboration agreement on behalf of its Merck Serono division with Idera Pharmaceuticals, Inc. of Cambridge, Massachusetts, USA (Nasdaq: IDRA) for the research, development, and commercialisation of Idera's Toll-like Receptor 9 (TLR9) agonists for the treatment of cancer.

Micrel Launches World's Smallest High Efficiency Dual Synchronous Buck Converter

Micrel Launches World's Smallest High Efficiency Dual Synchronous Buck Converter

Dec 19 2007 | comment(s)

SAN JOSE, California, December 19 /PRNewswire/ --

Micrel Inc., (Nasdaq: MCRL), an industry leader in analog, high bandwidth Communications and Ethernet IC solutions, today launched the MIC23250, the industry's smallest high efficient, dual 400mA 4 MHz PWM synchronous buck step-down converter housed in a tiny 2mm x 2mm, 10 lead MLF(R) package. This device is ideally suited for today's portable applications where high efficiency, low output ripple and small size are crucial. The MIC23250 utilizes a proprietary switching method called "Hyper Light Load(TM)" that achieves high efficiency, very low output ripple, and fast transient response while using very small output capacitors. The MIC23250 is available in volume with pricing starting at US$1.47 for 1K quantities.

Rio Tinto Alcan Launches EUR 15 Million (US$22 Million) Investments At Neuf-Brisach Speciality Aluminium Sheet Facility

Rio Tinto Alcan Launches EUR 15 Million (US$22 Million) Investments At Neuf-Brisach Speciality Aluminium Sheet Facility

Dec 19 2007 | comment(s)

PARIS, December 19 /PRNewswire/ -- Rio Tinto Alcan today inaugurated a new EUR 5 million (US$7 million) remelting furnace for the recycling of used beverage cans (UBC) and a new EUR 10 million (US$15 million) trimming and slitting machine for beverage can body stock at its Neuf-Brisach site in France.

"These investments strengthen Alcan Specialty Sheet's position as the leading supplier of the rapid expanding European can stock market," said Christel Bories, President and Chief Executive Officer, Alcan Engineered Products. "Neuf-Brisach's fully integrated recycling, rolling and finishing facility makes it unique on the European continent," she added.

Online Christmas Shopping Activity Hits Highest Point Of The Season To Date In The U.K., France And Germany

Online Christmas Shopping Activity Hits Highest Point Of The Season To Date In The U.K., France And Germany

Dec 19 2007 | comment(s)

LONDON, December 19 /PRNewswire/ --

- Online Shopping Activity in France up 45%

- Leading UK Multi-Channel Retailers Enjoy 30-50% Increase in Visits in November

comScore, Inc. (Nasdaq: SCOR), a leader in measuring the digital world, today released its third study of the online shopping activity of U.K., French and German consumers this Christmas season. This study tracks the number of visits to online retail sites each week since the start of the season on October 29, as well as the fastest growing online retail properties in November, using data collected from the comScore World Metrix audience measurement service.

Busiest Week of Online Christmas Shopping Season to Date

NTT DATA EUROPE Offer For Itelligence Successful

NTT DATA EUROPE Offer For Itelligence Successful

Dec 19 2007 | comment(s)

TOKYO and BIELEFELD, Germany, December 19 /PRNewswire/ --

- The Offer of NTT DATA EUROPE is Successful With More than 89 Percent of itelligence AG Shares

- All Conditions for a Successful Transaction Have Been Fulfilled

- The Additional Two-Week Acceptance Period, as Required by German Law, Starts on 20 December 2007 and Lasts Until Midnight of 2 January 2008

Endeavour Increases Capital Expenditure Budget For 2008

Endeavour Increases Capital Expenditure Budget For 2008

Dec 19 2007 | comment(s)

HOUSTON, December 19 /PRNewswire/ --

Endeavour International Corporation (Amex: END) (LSE: ENDV) today announced that the company plans to spend approximately US$90 million of capital during 2008 to fund oil and gas exploration, development and producing activities in the North Sea.

Top Tips For Safety On The Slopes

Top Tips For Safety On The Slopes

Dec 19 2007 | comment(s)

LONDON, December 19 /PRNewswire/ -- Now that the first snows have come across Europe and the US, skiers will be tempted to rush out and get some action on the piste.

That's just the moment accidents can happen, warns Greg Lawson, Group Broking Director of online travel insurance company Flexicover.Net, as he offers some timely advice to help skiers stay safe on the slopes.

"Winter sports can be dangerous but there are all sorts of things skiers and snowboarders can do to make sure they have a fun and safe holiday in the snow," he says. These are:

BASF Podcast: The Chemical Reporter - How Is A Mirror Assembled?

BASF Podcast: The Chemical Reporter - How Is A Mirror Assembled?

Dec 19 2007 | comment(s)

LUDWIGSHAFEN, Germany, December 19 /PRNewswire/ -- When you look at yourself in the mirror, you could be led to believe that the glass is doing the reflecting. This is not so. The actual mirror is well-protected behind a plate of glass. In entertaining weekly episodes our Chemical Reporter answers questions on Chemistry in our everyday life.

Direct subscription via RSS-Feed or iTunes (search for "basf"):

http://corporate.basf.com/en/podcast/reporter.xml

Podcast The Chemical Reporter, English edition:

http://www.basf.com/podcast

More podcasts:

Podcast Chemistry of Innovations:

http://www.basf.com/podcast

Mantissa Gives You Protection Against Identity Theft & Credit Card Fraud This Christmas

Mantissa Gives You Protection Against Identity Theft & Credit Card Fraud This Christmas

Dec 19 2007 | comment(s)

LUTON, England, December 19 /PRNewswire/ -- With immigration and benefit fraud at an all time high and constant news of security threats from incorrectly managed data, Mantissa Corporation wonder just what they must do to make themselves heard in 2008. Throughout 2007 they have contacted numerous politicians, government departments and wrote separately to every member of the House of Lords.

Tamir Sapir To Fight Frivolous Litigation And Attempt To Block US$28 Million Judgment From International Arbitration In His Favo

Tamir Sapir To Fight Frivolous Litigation And Attempt To Block US$28 Million Judgment From International Arbitration In His Favo

Dec 19 2007 | comment(s)

NEW YORK, December 19 /PRNewswire/ --

- Russia's Highest Commercial Court to Hear Appeal Argument Based on 'Newly Opened Circumstances' - a Question in Punctuation and an Allegedly Errant Hyphen;

- Hearing Set for January 22, 2008

Moscow Oil Refinery (MOR) is blocking New York businessman and real estate entrepreneur, Tamir Sapir, from executing the 2005 landmark US$28 million judgment initially decided by international arbitration and later upheld by Russia's High Arbitrazh Court after a protracted legal battle. The judgment against MOR was in favor of Mr. Sapir's company, Joy-Lud Distributors International Inc., a New York corporation.

Novagali Pharma Strengthens Its Executive Management By Appointing Dr Mourad Amrane To The Head Of Medical Affairs

Novagali Pharma Strengthens Its Executive Management By Appointing Dr Mourad Amrane To The Head Of Medical Affairs

Dec 19 2007 | comment(s)

EVRY, France, December 19 /PRNewswire/ --

- Not for Distribution in the United States, Canada or Japan

Novagali Pharma an emerging pharmaceutical company specialized in ophthalmology announces today the appointment of Dr Mourad Amrane as Vice President of Medical Affairs. He is in charge both of the clinical product development and the medical marketing activities, which aim at defining and optimizing the product strategies.